0001104659-23-036775.txt : 20230327 0001104659-23-036775.hdr.sgml : 20230327 20230327060132 ACCESSION NUMBER: 0001104659-23-036775 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20230327 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230327 DATE AS OF CHANGE: 20230327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Healthcare Trust, Inc. CENTRAL INDEX KEY: 0001561032 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 383888962 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39153 FILM NUMBER: 23761344 BUSINESS ADDRESS: STREET 1: 650 FIFTH AVENUE STREET 2: 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-415-6500 MAIL ADDRESS: STREET 1: 650 FIFTH AVENUE STREET 2: 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: American Realty Capital Healthcare Trust II, Inc. DATE OF NAME CHANGE: 20121025 8-K 1 tm2310583d1_8k.htm FORM 8-K
0001561032 false 0001561032 2023-03-27 2023-03-27 0001561032 HTIA:Sec7.375SeriesCumulativeRedeemablePerpetualPreferredStock0.01ParValuePerShareMember 2023-03-27 2023-03-27 0001561032 HTIA:Sec7.125SeriesBCumulativeRedeemablePerpetualPreferredStock0.01ParValuePerShareMember 2023-03-27 2023-03-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported):  March 27, 2023

 

Healthcare Trust, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Maryland   001-39153   38-3888962

(State or other jurisdiction

of incorporation)

   (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

650 Fifth Avenue, 30th Floor

New York, New York 10019

(Address, including zip code, of Principal Executive Offices)

 

Registrant’s telephone number, including area code: (212) 415-6500

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbol(s)   Name of each exchange on which registered:
7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share   HTIA   The Nasdaq Global Market
7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share   HTIBP   The Nasdaq Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

Preferred Stock Dividends

 

On March 27, 2023, Healthcare Trust, Inc. (the “Company”) issued a press release announcing the declaration of a dividend of $0.4609375 per share payable on April 17, 2023 to holders of record of shares of the Company’s 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock at the close of business on April 6, 2023.

 

In addition, the Company announced the declaration of a dividend of $0.4453125 per share payable on April 17, 2023 to holders of record of shares of the Company’s 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock at the close of business on April 6, 2023.

 

A copy of the press release is attached as Exhibit 99.1, and is hereby incorporated by reference into this Item 7.01. This press release shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information in Item 7.01, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.

 

The statements in this Current Report on Form 8-K that are not historical facts may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results or events to be materially different. The words “anticipates,” “believes,” “expects,” “estimates,” “projects,” “plans,” “intends,” “may,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to a number of risks, uncertainties and other factors, many of which are outside of the Company’s control, which could cause actual results to differ materially from the results contemplated by the forward-looking statements. These risks and uncertainties include the potential adverse effects of (i) the global COVID-19 pandemic, including actions taken to contain or treat COVID-19, (ii) the geopolitical instability due to the ongoing military conflict between Russia and Ukraine, including related sanctions and other penalties imposed by the U.S. and European Union, and the related impact on the Company, the Company’s tenants, the Company’s operators and the global economy and financial markets, and (iii) inflationary conditions and higher interest rate environments, as well as those risks and uncertainties set forth in the Risk Factors section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed on March 17, 2023, and all other filings with the Securities and Exchange Commission after that date, as such risks, uncertainties and other important factors may be updated from time to time in the Company’s subsequent reports. Further, forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise any forward-looking statement to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time, unless required to do so by law.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
99.1   Press Release, dated March 27, 2023.
104   Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  HEALTHCARE TRUST, INC.
     

Date: March 27, 2023

 By: /s/ Scott M. Lappetito
 

Scott M. Lappetito

Chief Financial Officer, Treasurer and Secretary

 

 

 

 EX-99.1 2 tm2310583d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

FOR IMMEDIATE RELEASE

 

Healthcare Trust

Announces Preferred Stock Dividends

 

New York, March 27, 2023 – Healthcare Trust, Inc. (Nasdaq: HTIA / HTIBP) (“HTI”) announced today that it declared quarterly dividends on its outstanding preferred stock. Specifically, HTI declared a dividend of $0.4609375 per share on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) payable on April 17, 2023, to holders of record at the close of business on April 6, 2023. In addition, HTI declared a dividend of $0.4453125 per share on its 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock (the "Series B Preferred Stock”) payable on April 17, 2023, to holders of record at the close of business on April 6, 2023. on a quarterly basis.

 

About Healthcare Trust, Inc.

 

Healthcare Trust, Inc. (Nasdaq: HTIA/HTIBP) is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing and medical office buildings, located in the United States. Additional information about HTI can be found on its website at www.healthcaretrustinc.com.

 

Important Notice

 

The statements in this Current Report on Form 8-K that are not historical facts may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results or events to be materially different. The words “anticipates,” “believes,” “expects,” “estimates,” “projects,” “plans,” “intends,” “may,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to a number of risks, uncertainties and other factors, many of which are outside of the Company’s control, which could cause actual results to differ materially from the results contemplated by the forward-looking statements. These risks and uncertainties include the potential adverse effects of (i) the global COVID-19 pandemic, including actions taken to contain or treat COVID-19, (ii) the geopolitical instability due to the ongoing military conflict between Russia and Ukraine, including related sanctions and other penalties imposed by the U.S. and European Union, and the related impact on the Company, the Company’s tenants, the Company’s operators and the global economy and financial markets, and (iii) inflationary conditions and higher interest rate environments, as well as those risks and uncertainties set forth in the Risk Factors section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed on March 17, 2023, and all other filings with the Securities and Exchange Commission after that date, as such risks, uncertainties and other important factors may be updated from time to time in the Company’s subsequent reports. Further, forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise any forward-looking statement to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time, unless required to do so by law.

 

Contact

 

Investors and Media:

Email: investorrelations@ar-global.com

Phone: (866) 902-0063

 

 

 

 EX-101.SCH 3 htia-20230327.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 htia-20230327_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 htia-20230327_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Class of Stock [Axis] 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share [Member] 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share [Member] Statement [Table] Document Information [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share EX-101.PRE 6 htia-20230327_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 tm2310583d1_ex99-1img002.jpg GRAPHIC begin 644 tm2310583d1_ex99-1img002.jpg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htm IDEA: XBRL DOCUMENT v3.23.1
Cover
Mar. 27, 2023
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 27, 2023
Entity File Number 001-39153
Entity Registrant Name Healthcare Trust, Inc.
Entity Central Index Key 0001561032
Entity Tax Identification Number 38-3888962
Entity Incorporation, State or Country Code MD
Entity Address, Address Line One 650 Fifth Avenue
Entity Address, Address Line Two 30th Floor
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10019
City Area Code 212
Local Phone Number 415-6500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share [Member]  
Document Information [Line Items]  
Title of 12(b) Security 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share
Trading Symbol HTIA
Security Exchange Name NASDAQ
7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share [Member]  
Document Information [Line Items]  
Title of 12(b) Security 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share
Trading Symbol HTIBP
Security Exchange Name NASDAQ

XML 9 tm2310583d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001561032 2023-03-27 2023-03-27 0001561032 HTIA:Sec7.375SeriesCumulativeRedeemablePerpetualPreferredStock0.01ParValuePerShareMember 2023-03-27 2023-03-27 0001561032 HTIA:Sec7.125SeriesBCumulativeRedeemablePerpetualPreferredStock0.01ParValuePerShareMember 2023-03-27 2023-03-27 iso4217:USD shares iso4217:USD shares 0001561032 false 8-K 2023-03-27 Healthcare Trust, Inc. MD 001-39153 38-3888962 650 Fifth Avenue 30th Floor New York NY 10019 212 415-6500 false false false false 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share HTIA NASDAQ 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share HTIBP NASDAQ false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

U:JQ"(6,P$ "(" / M " 0(1 !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 " P M,'M6)!Z;HJT #X 0 &@ @ %B$@ >&PO7W)E;',O=V]R M:V)O;VLN>&UL+G)E;'-02P$"% ,4 " P,'M699!YDAD! #/ P $P M @ %'$P 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) + #X" "1% ! end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 3 23 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://thehealthcarereit2.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2310583d1_8k.htm htia-20230327.xsd htia-20230327_def.xml htia-20230327_lab.xml htia-20230327_pre.xml tm2310583d1_ex99-1.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2310583d1_8k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021q4": 26 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "htia-20230327_def.xml" ] }, "inline": { "local": [ "tm2310583d1_8k.htm" ] }, "labelLink": { "local": [ "htia-20230327_lab.xml" ] }, "presentationLink": { "local": [ "htia-20230327_pre.xml" ] }, "schema": { "local": [ "htia-20230327.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 65, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 2, "memberStandard": 0, "nsprefix": "HTIA", "nsuri": "http://thehealthcarereit2.com/20230327", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2310583d1_8k.htm", "contextRef": "From2023-03-27to2023-03-27", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://thehealthcarereit2.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2310583d1_8k.htm", "contextRef": "From2023-03-27to2023-03-27", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "HTIA_Sec7.125SeriesBCumulativeRedeemablePerpetualPreferredStock0.01ParValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share", "label": "7.125% Series B Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share [Member]" } } }, "localname": "Sec7.125SeriesBCumulativeRedeemablePerpetualPreferredStock0.01ParValuePerShareMember", "nsuri": "http://thehealthcarereit2.com/20230327", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "domainItemType" }, "HTIA_Sec7.375SeriesCumulativeRedeemablePerpetualPreferredStock0.01ParValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share", "label": "7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, $0.01 par value per share [Member]" } } }, "localname": "Sec7.375SeriesCumulativeRedeemablePerpetualPreferredStock0.01ParValuePerShareMember", "nsuri": "http://thehealthcarereit2.com/20230327", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://thehealthcarereit2.com/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0001104659-23-036775-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-23-036775-xbrl.zip M4$L#!!0 ( # P>U:)AL;C 0 ,D/ 1 :'1I82TR,#(S,#,R-RYX MN4V+3N,9QW+SD".T .F@E(FD- MSJ_O2+L+&# ?CGW*DS[NO9J9'8V&YMMI*L@=:,.5; 5QI1H0D$PE7 Y:P:=N M>-P]:;<#\O;-+S\3_#5_#4-RQD$D#7*J6-B6??6:_$U3:)#W($%3J_1K@R8E*QP(LX$9^4H,<5.)#QD@8[B!\ S)1^M-5>R8\M'9L&E$TF4PJ M4MW1B=(C4V$JW4VP:ZG-S$RM.JT6O]WH'6[8C/R*'A],#J=7_'8 \H_L@M:_ ML,_TOG/>^YA\_W+UZOS?T=2F[VJ]&W%^>__GJ,>RNZ,N:]_H3FWT^9\/^9%- MPX:04H)?0YI6X/PKW)O4*TH/HEJU&D>WG8NNQP4YL#$57([6P>.CHZ/([Y;0 M%>2TIT4I78_<=H\:F"GC+M^ Y])8*MD#?&)GA$7P091O/H#RM=#?1Q.W(;3MFU3%K,^9?U^WC&P+"DU:0#YT> MJGO%!/I<@IS6@9O""1&4@^RC=^/-9@D.?]N,"%@EA M'B$Q*E@F]N/,35E+*1;*>,TC6-[!*^@3?W<;+CE:@>&N? ;%VE!#W\66T[#\ M4%_1M0KF30EQTAONKH_\. M(>X<$Y#H.5P6M+>ORT@!\8*^7CC]9W42,VE?)Q\FWPMY>CH[9-'=HC)$\])0 MS)?+1Q,=5]H2N5*1-CTT^1-YH9B7VD!QL[#DA6XIC&M8E2M3D\PMW<>(>1CV M,Z+D/<&(1Y^[=1:8QPEN&.;#78_>^'1N/'XM,P)A3;D2SK6>8L[J0_L#]GBQ M)QBT_0U_S*AM3#\W3TH1IC)I];WW<,ZXK1ICUC-678 M)EJ=85F37 @G590[_7*L.>/)?C"-D:Q+A6>/KN^:/X[-K_U8\.@8'+0D /]K 5 :'1I82TR,#(S,#,R-U]D968N>&ULU9U= M<]LV%H;O.[/_@:M>R_J*UQLW;D=6[*ZF2>RUW'2W-QZ(A"2,04 +@K;T[Q?@ MATQ2."256'"1"T>F#H#WG <$<$B0_O#+)J3>$Q81X>RB,SCI=SS,?!X0MKSH M_#[KCF>3Z;3C11*Q %'.\$6'\[)I@&Y]Y'[G>G;,%_ M\KZ@$)][OV*&!9)<_.1]13361_@UH5AX$QZN*998?9$V?.Z=G@S.?-_K=EM4 M_!6S@(O?[Z:[BE=2KJ/S7N_Y^?F$\2?TS,5C=.+SL%V%,XED'.UJZV_ZV;^T M^ =*V..Y_C%'$?94P%ATOHG(14>WFS7[/#KA8MD;]ON#WG\^?YKY*QRB+F$Z M<#[NY*5T+:9R@_?OW_>2;W/3/!D$P6=G%,2;,$IOL,+ M3_^O0.]:E2N\PHC*E8\$%IC(H:;[6@B3/67:RVQZQ@J.KWO76#?@(2('BMXO;4%QTE(WQ.%N*SQ\A))$ZF+93#/PNGI:BI4JJ3ZFEIF@7!+E?DD'U6,RWQOR MTJDP\3S"_LF2/_4"3%04AX/_O=,?N^G'-(R8/.3MZBE1A"CS&4\E#J.\$Q63[JCSV%Q%-,, X M\T;E$)!AWV4B#P.#_->"DD^BAXYZKT8M\0X"-_IV<-4$XE_WT_'##/MG)Z.S MTQD6!$>3.(RI&JV?U HGP"I94J/ +19K+&-$;U4]6 @<)%K[)_W!+1))HJE, M9BNU2/B&N,1AF^B^/WC=> MN:D'TQCWU^HUL<5T]Z>:'FL/9$=D48-L,/H6D^A4W$1Y(Q"=L@!O?L/;NO!73)V)OTDW",!B\IRJNQ4D1&([(W[S ML%.U=0:!43C(P&+&G,J[1YMIH'PB"Y)N4&Y& 11QADB=?A",Q90Y53EE/A=K M7K@2/^&Q.INW$Q[43A6U!9V!U.P%B,IB7IUJ'0>!P%&4_:=]&]0!,I@[@P72 M#MZTLYAC0PJ'A\$8.@QC6 _#8HX-*1P=!F/D,(Q1/0R+F79)X41]O!'W_!G8 M3P 8NP:BHAS$8#W-SO0E<]J-N!7\B:3/BC6QJ)1P#8A)/DC%>BJ>]YITD='F MS$@M7:-0E U&WWHJGHF[Y9%$]$^R;EKCFNQ=([$O'N1A,3//^H>^< -M."N9 M.!#U?;U@H"VFWWI^&@N,X*Y>M' AS%6Y8)0MYM*?N+X'M>*L]LIVUU C,M:H>!^Q[,Q!P?W#T&DTC3A81BS[.H5<-_2:.I MT&'=( "+:>V,4^*K6+'E9[6:%011<_3W[1P(/2 :C+O%#/968-TCL$HD#(8.Q!U2#8;> M8M9:4F8.>LG$@7#OZP4#;3%KS4^^JXV_0FR)X7TK)DL'P@[*!J-O,9M]&?J6 MK<;TI7MC^K+%F&XQF\V%I0\[J//Q9D[)$L%/8]84<(@#I!Y"8O+L6$C29^,* M#EVK#V881E,',,"Z00 V'TV. R)QD(J\)@PQ7Z6*NX=%@>L13:5QHMVYVB*M:U6!,Z#: M>P,BM/]H- ]#_=@=]Q^3-[U&-[%,_H*14EQ[F:2FG#/ &IT .;W!Z\>BEPO^A5W%3-?^HOLN.ZQ_Z M+S"I(_\'4$L#!!0 ( # P>U:V*X!2Q0P $"8 5 :'1I82TR,#(S M,#,R-U]L86(N>&ULS9W];]NX&<=_'[#_@?/= 1M0Q[&]+FBNO4/B)G?&I4E6 MN[UMQ5#0$N,(D44?)>7EOQ])O5BB^$A*5I/L#ZTK?1_R2_$CDGHA]?;GQTV( M[@F+ QJ]&XP/#@>(1![U@VC];O!I,3Q9S.;S 8H3'/DXI!%Y-XCHX.>?_OPG MQ/^\_#B(Z#U^ MH.PN/O#HIE^"BP0G:5RF=OAXF/_)PM^&071W+/Y:X9@@?L"B^/@Q#MX-1+YY MM@_3 \K6H\GAX7CTKP\7"^^6;/ PB,2!\\B@B!*IZ.+&;]Z\&^">CB1]=Z9#0(5XG_#0C84FX;CR7 Z/GB, M_4%Q\.419#0D'\D-DL4\3IZVG*4X$"@,\FVWC-SHS82,C43\*")KG!!?9/1& M9#3^A\CHNWSS!5Z1<("$DO,!ENM-+:T\:&3:[#5A ?7/HI>Y5J,MV>?G#DO^ MCP)4XXT784D3'+[(?#72N.U+\K(COHLS?Z1Y0T]>=J0KD7NQG30M/_OPZH]K M*#9>\%\UB^0QX1T8\0N3(HF6%ECF(#N&/.TR=>K5T@U%:TY9L^RB9Y1IWN!X M)1-.X^$:XRW/8#(>D3")BRU#L65X.,[;[^_RS5]%#TDV)$IF(8[CJYM%0KV[ MD\<@+G*317TWZ*$?J<40D2>L* MF7LT<'TZ/6"M^HDGJ6; M-.1CBWM^@OJ$#S56(>'M_98D*0ZO>3J$,>)+6X<'A^-KS.38BTL6MYB1#V2S M(DPY"OO+Q@22^SY(@N1]Y6']!-ASP=3S1F;S \HR0B=HEQ?:98;*W%"977:B MO4+?BRS1%C-T+S)%6W[1$XMLT9A>-)?HQ.]WL:?O-\S)Z'>SI,]1/Q M&V?BT)FXGY(U3T6>3WDJGKIY*G[;(=92%*EK!)"+K RF:@:U(RBIL,YJJRT5 MM%*$ODC9M\4B)M[!FMZ/?!)((O[XN_@YS'Y*#/A_O[ZG7BHLB'M3;"-OS?"K M!S+GQM2!=K?EI4 6G"$&5&/1%1"$99A.D)4^UI939;M.@ M5$VI8(A]3H%0,016O-!8J.03GKDO#)R'>*TI@K+?5#5K;17U7-OI1$7K'*DU M76J0$-FLZO=#?0:EOM%[1B)\#IXQ#L.:I!J(RRR-))%/&KJ(]D2UD;0G69 M:7)T)E5@JAJG.-$8 _'(M"@36Z3BGREF"6'A4R<8#:5I-@"K*AZ*S"E"]-Y M2$JY?4Z6#$=Q(!JS3E":4N.7(8#9QB6)HG.*%< !<)1 M=\.B$YLF!C:L,M-4.D4-: _D1D:@/,0M=,[NQ:B=#YUZ%KBBMPE0PW8;0Z78 M68Q4ASU)DF%(Q%FDJ?(B4@='#:5I@@"K*CN*S"EJ]-Y 7C(YDGHW0#F+_%Z8 ME#H[D"@V]8CD(@#C,_YWQ;VQ,;C=8T)*!=%92&T"E8 M('<@,%E P8T,L0[-OPEF_9"I*.T T["JQZ64.0B+ZJT+%:&W!LHL9:SF'.Y] M8*DI5+K,%JQ .B=@Z3#7>,;E+;W$%!^0N8(+ M=;\3/ "F5 XR&1(ZE FMU7[Q5"%*Q/0FL$BJS"P%>I-U$NH:AVC0&@.(V&GE M;#-K5,QX*\5P.(]\\O@;>0++UM"9Y0*P60=#$3E$AMX9@$8N1E*-N-P:'-J<@@0P!I 2*Y&B_G,=J^RQ(]SGP,;W 39K-$. M4D"]66 Z;->Y <0.X=/N$*"(!Z%ZE&V8YI%'V9967I>8T90WAD\SZL,CEHXH MLV#U*D(=K]80AR#KXQ- K1;Z*GNG!5$QY5\F@$0*UJ@[\7U^L.+\GXL@(F/P M&&BU9@EKL5OG2B-TB";8'49Q)_;!F?0%9^(T.).7 M@+-\H Z!,WU&<:?VP9GV!6?J-#C3%X'#*]]ZFS/C/Z_8DC[H7O@&E5:P:5K5 M0K.3N8=,PUL7,") C&]$B&U4Y&#KBETS>A]$'CR,AN16H %,:\E1M.[AHS?8 MQ5 Y2"[B;(.4#]8[3Y9"9J>UJ9O4-S69QCU0ZL8Z&YE,;1N+:QHG./Q/L&V] M2->+K2"B-:P%I:9T#Q>=O2YHLAC$@VQ==.?8B@<@VNEJRGYC3ZEUMLI'T]6= M3H"@<]1X")W?77YSC:T3 M6JP7&5[?T@A^N: I,57;D+FBQM7]3M0Z8$JM>2E#4F?QSKU8MR[6-^65?<9Z M>M5.V;$7.YRH8=5-H]LN]ENHT=]9D/#<9W2S2:/\R9#N'41 9ZJF6VT6M:X5 M.4% FS.5AER+ZF(+:"QH&'A!$D3K#_SBE 585S*=R!04L,&"B*;""1Q 6XT5 MB4HA*I060+AF1,!(>&7("8=BZ5)V=7.C[?W;Q*; Z#9< (KG0"ETYX*# \8 M>I4(E(4@&6,?G7D7J)L?X),%?V3LI^)_@ 3*D\R'UB7>'QY*^KOZ$BR@("EW3)L/A6 MQ>)ILZ(AL!*65F4*A!:+!0L:B1,XP+Y4(BXIRJ4HT]I:*:MF6%,D9;\I"+2V MBNJO[72BXG6.&HU K;XM-O]GC]XM-T: R0YZF>EN0&=2[0JJ&B5\S_D/34D!G;'U-MML ME@MNZD1.<-+FK+'D9K807G6%9:&VP4;J!PGQ,T/G080C+\!AN72C[NYY=X@Q M8GJ:+^'IT+O!43^3#:2RL&*-Q3)PMPRGC=ONV4L+K7KS;YUTV&[_N(-('8"J3X.@==O1-#P3D2A(BR_6V:-IL\T3*,$,SF' MG>E:*$!GEA[ 9IT:1>00+7IG "6E&&5J>Y/"L]4KRH%7]B54L)"0W/ 4\5;3 MRDQQK=8A;EH-0O/&\S5'=N/E+,KB=,Z$,.R)S_*\QPG._8%EAN2F)W"VF59G M;NJT#F'4:A"US165^\9J&Q>;Z-:7$(41T MOEI6L6&HT%KC8;'!87B:QD%$8KA34E1F>=!:K/-0DSC$@\X7P(.4HD)KC8>S M#6%KWMW]PNA#-"*^#PC.I.@.,4517_,%2UUZ)XCJ:5+E2H;5+[QEH/S6H^U5E:H+ M\L/#OIK(\&A98U 9+%<43G "VH*&RM7O&]A;SR]=A8%W'E(,WX6I:0ROXM>T MIRS@MQ,X1$'3%;1LGQ0BJ;3&P"F.[EBZ3;RG:T8]0L3;6G'9XY?@,)=$JB2QJM*[V7[AI]X&5VL,$>]._DI^/@J36+1HW)S M\!WSUB##CR)Z%$!Y(-$2X1!^/6Q"#R=D))*AKU 6C"K1%J_;XMWJA,0_??I( M;@@3,\N3 M0%]$(DBFTOJ=]CW4Y*_+^8EX6>[H8#QYO2 L(/'I+-VD(18/9#X2GY -7H7D MFK M25(<7C-AFQ%?GEJ'!X?C:\P^XS 5$GF>?2#JY=C>,OGJ4\\8(7Y>D[I7 M./==0I4JF<\/*,L)G:)=7FB7&2IS0V5V18OXO<@2;3%#]R)3M.77D['(UAI_ MTZ/\P.T1OV^;AX/T[:6 3?AX-B5\)_N%K[KI@O_BFXM-_*\5C@G?\C]02P,$ M% @ ,#![5N@]JH=Z" EV8 !4 !H=&EA+3(P,C,P,S(W7W!R92YX M;6S575USVR@4?=^9_0]:]]G?[6:;MMM)W*3KZ4>R<=KN[DL'2]AF@L +*+'_ M_8(DN[8ET$V;#&P?4D<^P#WG(,250'GY>I72Z!8+23A[U>IW>JT(LY@GA,U? MM3Y-VB>3T7C\__Q3I?R]_:;>CHL9%DAQ\2+ZC&AFCO!S0K&(1CQ=4JRP_J)H^#AZUND?Q7'4;@,J M_HQ9PL6GJ_&VXH522WG<[=[=W748OT5W7-S(3LQ36(43A50FM[7U5KWR7U'\ M)27LYMC\F"*)(RT8D\%B MW-J4,K74E>L_?_Z\FW^[@5:0JZF@FS:&W4TXVYKUM\2!WXE$DF.9A_>>QTCE MOC!:9_[5[VU;5 B\PHFH1 M(X$%)FI@K.L:6'?$==_4,><5+ 2>F5($Z78&P]YP<&1:>;('4NNE[J.2F"[6 MBKI[$2P%EIBIG/1[?6"O"%XIW;%PLJG(M'__&!51IEC9@?I1V_2V+-6MZH\% ML@QI$Q3E\5XI^=@N/N:*Z%^_YHV= M3*42*%:;VBB:8IJW\55C#B#='XYLAN0T[QJ9;,\16N;A=3%5XPYEV+3\1^_$C$FXKUQSU_J_VZ1'27VG"F MVO&"T&W7F F>VD0L&^3.J+E(L-##;:_W$*K#^L.F'YJ13Z2;) M7VMV WO#4T28W9,Z;&!FV#K8@2]U3$I#OM^/PPOW']?CDZ\3'!]UAD?/)E@0 M+$=9FE&MS:V>*B183U)TU[G$8HE5ANBEK@<+@9,\K%ZGU[]$(I^U:[0CS2,;:N^?&T4>C7NFY#]XM^H,RXM-'[Q@<2TYGR*_P3(69&GB;M!Z#^GMFO0#DM=0]3A^7.$Y,1F="6<[ M=7(/*)8BWBX#WS_$.,E[-.6$,7T5NL)++AJ\V$<"+7@:D 5U5#TJ_V>&A,*" MKB'B5\! _9\%I+^%L,\9C4!,$A,_Q(,J&FC"KP&98*/LT87) E-JGE\@!CH7 MZO! )XX""A.L$40^?S794 MP$ CG@=DA(6P=PO.6 (U8 L%IVK!Z7_ UJ/ZYT3&B!91G>MC#<]6:N!0%T+( MF!M9>W?B;XP$V(<=,-2%$)+H!L8>/!AE0NP%Y!R.[&BH"R&DSTVX;5+^PH4*GX(&;*3K3?U+P5)D5A/2-P\VE2Q4/U#R(O=?+T9<(U6 MXT2S(#-2K.QK]L%:!&I'"$DQB+TW5\8LYF+)=^ZGCWBFS]SUB"?.RT-#0:A# M(63+]U#"FT\G2:(5E.5_ADW?Y4XM'/SD+1A/'*P#(&1O9/O(Z :AY ^UW'S M(/%[;AXA+3ASWJRNHJ!2AY 'VSCZ&,3-?D=I'3-VO@8O80Q X HK#\I^$43I M*$8\33-6WHNR/'ZT0*&*AY"\.MEZ4'_"*8F)(FS^04]5!4&T7OHZ'%3W$%)5 M.T\/HE\*;#H UBE!OG+/[*06%[.9;11WX:$FA)"I-O/V;\98R@R+^UI24PIJ M3 A)*U0#'P,4CC,]9J[[@^FU>5N 97BJH*#RAY"PVCAZD/LCOQ;(O,]DLDZG MG-KW+=4"H:*'D)XZF'K0?2^6>L4/(%"M0\A+:]EY'$S.5O$"L3FV+SFI1T(U M#R%/=7'U.H[/0>/X_)[C> CYJHVC1[F+_0?ZW+N84C)']KV1S@+@/6$!F>!@ M[F.3:KY%;8?"N?Y0[X0%"O4@A"S7R=:'^EE"%$Z*L,X)0RS6&>!VMZ;E=D-S M*:@G(63 4 V\/2'Y@BE]Q_@=FV D.<-)D8:X'I)8BT"-"2$K!K'WYLIG3C,M MG,C7# O+F6*!0ET((05VLO6W1+=8);^]EA4O7W298"L!]2*$?!C"W>,"187- MR^O(+7Z#%"JC=%EB*P&U)(1L&<+=ZY8-,=(7LCEWKVHX $(-""&%=C#UIOLD M192>9E*'+9V#T@$0JGL(:;2#J3?=SU(LYGI$?"OXG5J4^YI=^EL*0'T((;<& M,/?GQ^K;RQ>*79U.,VK0X)=^A..$E;//=][$L5D!4TP66(*$Q0@7'FI%"'EV M,V\/9ERH!1:[L[8\($/!M5*EN134F!"2;:@&_B[=.V_$<%ZY]W!0"\))J^MX M^MORETTIB<\I1\Y\80\&E3R<'+J&I3?%3Q&[$=E2Q>M+P6.,S5,HN3TO ;D; ML *H2^%DU_=2QM_]#YZF9O,;CV_R5Z;*BTSE?UU#Q^B\"^(L!W4KG,0;HH/' M>9?\ME<1)Z?K*_/F6[.8Y!JOU*EN[,8]#0,4AUH60JI^;U5JG'O9K=#43=[H M;\MOS _S1T3TD?\ 4$L#!!0 ( # P>U8HOCML>A@ "E^ 2 =&TR M,S$P-3@S9#%?.&LN:'1M[3WY4^+*UK];Y?_0C_ON*Z=&E@ BH,,K!%3&!0=P M%NM662%IH"6D8Q8!__KOG.Z$-2@ZH'[OWKL(22_G].FS]\+A?X=]@SQ0VV'< M_!)18HD(H:;&=69VOD0\MQW-1OY;V-XZ[+I0#^J:SI=(UW6M?#P^& QB@U2, MVYVXDLOEXD.L$Y&5\L/0>LE$0HG_O#AO:%W:5Z/,=%S5U.BXD<',WO+^L71< MM64;;*8JO@F I.(+74.I/FDP73D3EX4S5=W0JGNRJAM490Y/)Y7]I_"0-<8- MALOJ*H@SC)#^/*J?3ZJ[X?4G5>.NK9I.F]M]U84YQ)[VHHED-)F9ZB3J4&VF M(WB.=?C#L_UDHRDEZ&=A:4*:PAA*;&]0);2-*0AKIKAUU1Q9UPM&" MXC@68\L$MDR.6VK<,UU[%#YROU #!HXMKN(&KP,P>JT62V.Z[I=VJ6JX78U MU:8V96XRIO$^MDHE4LG]B!!:JNKP2?"?0Y>Y!BT_BO:)0<,VKH>=*@[@&Y5/LT M3X;Z\(!4R^++;2)9O+UN_)DLGQ2+5_"!@R+1Z*JM4XE;'/1M^&!O@\&^H,=T M=MSJ-$9'MPG0<7L9!3I^2;^YJ7Z+ M?6KJ\+][;*B=V[9J./0%7>TG;QNUVZ;LZJ\RM=QC!EP.#PSEG&3AVQDI<53Z MI$G[EJ&ZU/GK\^?/4%"OU;!EQ: ('[[!Z[_*7//PL6J.U<,Y:(VJ2_M.#& Z M+\ NF$&!\A(J7, \VTZ1L#MTZZLUCF_>1 MDZ.)5#2Y[_+)]P@Q8=0 BK)\**]&"A-F/8S/@%@/U!E.CA0$*X<"BL\,%^&" MU@=)!PONR!IH7O*.\!L 2*<@7S7MQQ,C0;"'!LZ>L0O1AW])>(PX'$JE9_QV_)[I6-)FU"9B*#34*)>J M9[,S,]]X BX>"L^'9@%]N;Z(!7A&MEL&J2],AA#T-"E;: 93N:114#*/U@P" MP4N?I*O2>?+M5O,<%[1^@VK[L=3^'HH5=4I>WP,-QAYH'30H<$?+H%?4MJCK MJ<:5F&B;Z@V7:[U$+*%?,,%\F/[DJ$Z3JTMAEL<,B=20/N9WP#)#N.AV$V/ M+!X^M+\OTRI)?P:._N':5;EVS33[AVWSGLDDSX*+L\!"?:HZGDT+OB^4ASI! M9T'1+ CL;4G_TK%:"L(G@JCT:A@3!VX!#CA;P+N+M,6VPOE076XOLNX+:#"/ M8UBO4T#+U.1]9CX']GFZS,,-ZS@HGZ'" D%];VC*]Y&N6."''L:A/7SBOX=6 MX+OV5;O#S#Q)1"">M JSA:LZQ =DW U431P0Y-2H:K .O-) RE#!C;N?\N?K MGD&C5VI'!$73+K7L+^IR"^ G+3> $&UQ%W1PGJ3PW8#I;A<13/P9F6G>XC8, M6C8_,E2M1Z /XG"#Z0?$+PQZDN7*I!Q''778(P09\#92^,\?2B9Q(,GG_YT: M0GQF#!ND7X#&1B?I^K+:K)1)HUEL5AH;AM6HE*[KU6:UTB#%RS*I_"R=%B]/ M*J14N[BH-AK5VN6&$?A1;)Q6+T^:M:VL-6X;A6OR"'CJ6:0N%BY)Q+E$2Z(AH-4@.8,KK5QIF528[E,??CXO[[ MI79FYI+0W>\&E-/P(H5L]&P^FCR,(Z;PT=JL:GK'.0$!J%N:K5FQL& M=G5=;UP7 5JS1D#VFB!@1$F16ITH>SOZ)U([)LW3RML)_5C@BZ4F E=RJ?3_ MZD2CGT=XF]2IQ6V7[ 3/5 4;3AV7T >H26Q13/5/>8D5)J@*SPGLE7 7*]*9 M#)?7%'#T8(//F8$I]>EQ:>G\^,/Y\RKU>G'>;@ HZ+>CNXB&S!D4>"B+"_Y^<4X]1#**,Y(!_,=MT(]BU4(D'$IR$:[$]66" M\BW!V=7)8RJIO%I0IM0>KKUBJ.]2R^8/*$&S>F\%/(46'!FJJ3\I2OY75U^< MM( CELS)A#'#&J\ZX^EWFO'*S(SC:A>0IT7M\.F]LB_IG+5;3758]=.+FN#\IR8NG;E^U*KW]=/C]MHF;@D" MD4(J&TUEL]E<9F%A;,DTPA_[90HU^/:[E@:G[4DC*-0)X3;A;I?:Y,ZSF:,S M#8*?%^GSF8P"8H[40RRJ_V?S/RAFYY+$)!TR$)RYT>9%7;>IX_@?N$5$"=?DV=/SD?MXI Y*;&V:/ 1XI)#92X"T MMMTN*4*H["WL/?"E=W3S?X+B28)T2,*1C@W-[ M(2!>"*[>BS>2820LP=>:W>0#,YR K%7.I#*Y7I/OKYN"$]"1 @[Z%[=[O\P?.%#3 MH%:7FY28PL/:E=A,R*;:5!5TRY.=>7Y-^_R*LEZ$>LLY5*D:5[EN]KR:[*Z! M0Z?A10I)95G0\&E!PE(^QN<H]?/M6;^:R:\!Z'F:DD%;V MHF S$R\3J#?VV=;+_G>> U[I*%(H=2GX6! A$=4"W6K9#*.F%A^2%C7X@+"V M*#P&74RRT3/29@:R(W. -UT*&.O;6RXG#NM[AJN:E'N.,2(.>+M.>R2:^BUX M"R!+)YC+/NU)7M*#CFRBFJ.@K W.(A]@.U3X# ,0)[]N6FR6X"%!5[2M]IDQ MRI,?,#(4:R>RU+G\83,7"(P!F&?ZX8.S1#X>RW=G]]VSBTQN'<8VW^+7M+FX%-+,]V/&0@8$'<7$#2R3V? MF9"+&F!.H"4# $7-)3O*/BD=UPG0+085)U'LWX"M%)^M&ESL_X)*%R#H(.U& M.$]=IT\SHQNO=W9RMU&>6L3G31AJ G9[J^\#7N0F):U&E>040U6&6E8*&TNBHN+OK+DU\82GI#-O MRT^J:EWY3<.]]OEG%R%#EJXF5/WSZ0S""NN2S])S&EXRMP3@;Y#(5D4RH3'J MM[BQ@^F5%Q)D;L+?@B;S/+:_=K+@1IEEC$-]'>B7F_)ST&5!A8E266"O\.3; MD[RVSH$M"2Q]A3A2DBTA,J'6\M8_K0+5EQU7N?4/^8@>UWW.ZO;1*]Z?\,II MNO[C)1L6WN;*1()B#)!"89 R5CJ$2 W27_1LB@1FWR M@+")A0>8$/HS'L.J&NUI\7QKM@S""%\W2=7T07E2O\AEOK6,"^OH);NZWYPG M9T@I3Y6M@W6D(GY?[FF":[9L1]ZM]67Y)+/)& MC#2_[H8F<'')+8S:$3"ECJ[>+UMH.S%X"S3>A6KWJ/MQ+65BLY9RS6<[;Q^/ M:N5!KY^SW([^^]RT[M.ZS]A* #>VE4T%2\+G.YM8; MH9622Z7(#M)K_T L.R;VMK=$;X OS*^%IV\"X-SV4[')5C3Y"I@S^5H)/#T& MCFG;2;_,V=X*P/O08Q\^.SG309!F#/)(B,$L(XG]QZ]6B9+'*[/\1.;895G? M*RS$RNU=0?\GHON2[#U\_6+XJ\%;EV;U!W_]2;95UB^>0&S%I8L-[Y.9UQ.O M7BJIMJ=5QO;6[!SCIK50!<06MJ]T06U0@VHNJ V3BT4%SZ&B%B L=LD0<=$D M$PL-\M(2G P!RQ@A@PT8@ :PVULFX M%-GU@#C0$;:2:&JY/JYJX2A%KXS6? MNFKKCMP?HR];TDCMJ.,EC6GU$%O*P6$+<<&L;WBQYZ6W7:1"+KN0-V"\X+:+ MJ/!)^R0AB>P#U[SU<.(1N)>I"#R]2<>D^_6>O),D@ M^4)N5IFFJE4(KF%9 &]3M1=M41 @P-$2.$^#S"SABY>"G)[,-<_C+.>O:T9; M!;R=DNR##QH+=1S^2()3F\Q%< NJ\&CQ7$^9E)FC&1ROVHEMXI3RVSB,(+_ MAJ##/5./!HY2E[EB+W9A+G, 0T:M"<$"V+)-G<=>";& -.^(1MR0\<[7:&U33503/C-O[?4-WQ3B(K-UK^Y0K.]I;JB7Y09<<*^Y3D0,L"8 MQQAF)(*Q=YO3=Y:XJDG0/\=9WIV> Z"=9 ?TB%;AAO1>"E36(C>0-3'#]M9O MYB#)/\SP'/@BN+G6>&OWC';8WL*XW755\*]UO)ZB,NRR%G-)+A=3=D%WZ!C8 M0[A/P0>?'*2%NO \OL\6]Z)S&5-/&< F/L_J(F %PQ N>@MY#UQ_/=!F;690 MW==EVUOHFV. MU2S=P^@T3?WMK47R([G\O?Y+MI#QT%W9?I9DFB*[&%Q!=&,(,6J+KCO4I#:( MW\QIZNTM WKWT#>#@3D>V#")PO^VK,F$K1-D6?$LAN3^D@>*"4) _^XD].Y@ MYK>W\.2&X O4H#BM4-GE-J:425O5H(>^.L*Y!D89 .&C!N<]/\[T80A67&0AZ&9XB XWG7PV882R\0P*-$4,R M.@Q"6I23)4+@JUR9'+(X_M:$2.WH^,,$E%! !\41QK;#/HE*'9G;+]6^5\M1 M)0<.$$QYGVG3VEL5VAXE3.U1$P<6S![J7 B7W7'[7>@XZ)ERBZ/AT(1>A3$( M.P+"YM' N'"SPQ%"'TM4>X0=MPVFH65P!Y1BDAPX4A4CO>[9 )."O9J@!J97 M4,Y138GDU"Q;U 2.%%3IHRT=T_<:;VO >A7/YA:%./;:%*XDOI.3(WN%=GC5 M%3>G66$WW-$#6JM""L*X!J"(.VR=,0B?[N!&FKP_$J\GJ;B^6&EQ)$) 4* H M6%D94?M4DMZO[*_+.CA>E%=@*W=["ZTHH>8#L[D9R*9#!A1$$CY!2)_@((>Z MR(!N5ZI]<%.A(CF6$@.EVO0AN_EQ%DT314 :"!%2B:-]2@+/]OD&&F^I(U*Q ME*DF+[).*<*)31+A)R'!92&$=!U M;5?X#<"N>&N>H(DPZL]H"^0>> ^&S]<;@3GS+%VPB11JL+*"K?&3F:'D 6WE MB.P7SI&@$0CTL6Q!@+'+R.A"?LJGGH.V,N'+'TE M%%L'E/+T*4E,(@OTA?[(%X03EUR?_IGKCUZ_?9XT7F9 M.IK-+'F35>O5%W$=JD3^DHS;3Z:4Q%XVI2NW=)C+1958U^V/J8M[%:(P8S;H MUCSXH&)DD0)&BH=Q=96Q_2ZH*Q'$UV40OTND3I]-6<;&J+R"$DHBOJ)Y?%YG4=;[K_B#<.KRFK M$P;Y:FI=788>PL<1AM[?R[-"NB]DQX#N@;,H E-=9F^DP^GG/AS 3#K:8'_A M15$-=OC-O2^X5E'CB+SY M)9*,+&FMR-8S:ZO+5_=:A=-*\;QY6BK6*Z19OVXT=TGULA3[_5LTY[9$[25> M=6UJ<*3N=QJG]U=I_?H1AG>]!M6)%ZWGY[R(EU[.>33*O^Z08WAW<2=.&AJT M(1B-'FS& 3S M35O^NI MHC50X#85":Y@*7Z#7MA;!7$K>&:I U*3Z8$\S('C?AQ'[0UWWX ^ MYCK^N-FA^,7?PHJ_I)H]NA7;^V1"?O(+K/3K2.E='I\-'HO772O7V4\5.;VC M&>ODXH+:VO=36NU;]01C1_H-S=QT6]\O:PF/TU%+2S1^_MBOU'):J=3LFE?Q M>/,AW3DI:K;><.ROIUWUIO_PZY>K_!BPHYY7:9>L7KG5TQ_U8;)\53[^;%RR M;VIZ+QL?].HWY>_VY7FM?I&L?GW85W^>7'1:M:_]00:"JMSP=%!CB<1 >_A> MN?SIWOSJUWKWE6+BJ]KH_;"^\J.CQ&DWDTI?5Y/W=\-]A9TU#/5^J(^JK='7 M1..B'B]UZ,.)ESD[ZCY<9TH)F+GK5I$IK>M:(MF_4R% =<)4NPW-ZWTS;*,^ M_'5R?'=&2Z>]G]^]FU:V63_RG,MT]\?/]@EGYEWID2KN_N>3XK>C\UKIJO-8 M+3:/*NGK[-?.\&>YUW"K9QU]-.2M]IV::.S=EYUX^4;9_USJ)S+QP;Y;M8R; M7*Z6.G[XK"?5GQ?MY,_DT;=S[]@M?I'3^7]02P,$% @ ,#![5N9-3SS4 M!P $AD !8 !T;3(S,3 U.#-D,5]E>#DY+3$N:'1MW5E=3R,Y%GV/E/]P M%^TB6LHG3-,-9- &"--HH!M!&*F?5DZ5D[BI*A>VBY!_O^?:54D:TDQK=H-6 MRTL1EWT_SSWW.NE]&EY='M=KO4^#_AF>Q'^]X<7PB?'@Z>I&BE'!P>M;J]] M!RT+\=_%?5')'/ MM<[K?/_>T>B#'Y,3L=B3FXJ'(%*8ADE@C/Q4 B#3"5SBJML MD,ZP!8_"62>R6&43RJO4U6N6<]>BVUQ&:JPBD23S!INPE"D6LDB/Z>^=UB_[ MG8.]#^\IEX;LE %8JOC0PO(_?!01WCZ=%FF1"*<>)=W(6,I4C!))U]+DTA4B M62*H7@L0VG%32:7?"RG/<+8(1B[F7AZ4]W.C$NJ6\6\@.C3522R-99.-C+2! M'XY8?)1H*WEY5%B526N7 O8;]1H+:"$Q).)8.:6S/XW&+^_WNKMKHX'E131. M?CX:P<]Z+40#SKJCA9"W#(8_WZK7L"16D#425MG6INMKHS2Z6L7]$2J#GK-I MJ,VW()*W<72]?]]S3[MD'F7K-4%Y,4I4A'P;.5$6J0?F#*20!(TX22I[Q'\I M")B<[S]C'146FQ@NT4.A##.-+Q= #]R"5[DV;JP3I1ERTZ5)*W(;-%-N"J8C MF>93AIH'H)69TD#P5#-0(1?UE\J8"0NR0%P2$%8)LQL"D^@(HF+8Z%%^ERGG M*P:+MD7]LK)Q5&5C;5+!GT@$(*#8(V@?23A49'%5S3,YLI""R*#3WAW/9K/6 MT@$? (6 1CKMM>^.-UP=_QOM[R+E= KD_[-V2, ;J7W-Q[6Q^LM#Y!#0\9AD MD-L )F7!X^!?>'TCV7_&QSDP1!^;OX=^S(#.M"/L==HP0NNUL8@@(47+]K@R M,V'B9J+U/6-YJ:-%T&E?V\%EIQ.T$*/LO?5EP ,!\J RQRW"FQ#I(HD!8]0C M:M%W%R-MD3@N)D/RT8M"8X U0#^\Y[Z/4AVCN>"=MX-F:!2V:L?(LXI4SA74 M*+M.]6HD$P61+];E$X8*]W(9>4E7Y>#J5K[*C?ZV[DB>B.S%(ASF^>;Y,H+\ M?&FFDN3%&H>H6N,P6I4JM/AZ#68C6!:48'TN@QX_\^'_"42PC;88<>#81$%9D8XPC'"S9Y TGB&$ MG=709XA1"5)M /9G/?/I@ISK)]A,"W"&BS6:TRAISK-L6G;6 Y8L-OHI%$> M^3'@V*2 JU6DC8U./357NU@>"#_QM#V:^W?/?.99]7FA_*@*P,5) ?-93*X= M1Q4FB9A;D20)<[@>X?&.>NIA;G&] <"59ZAPMS_E6I3+X,%+XB&HK),O@/3J;:-:0 M\AMAYBQXC.[K4*!N)J'LI@ BA??T[MY I\2LNC3-R! Y*[)@Y$J6FB4//#R6DA.D(IS\)V9;@4*#5J#"\0&VGP5K$,- MM!C!D%NH*...H333Z=POCQ4D1)PO\/&]]!6%9004$47#3GR[+J,4.GF0-U43 M]I?K%;!R]9KA.45FC\KHK*I-[N0H2<%,J5]!D)4\T1B,(N40<8.-=!XJ!F]] MF!E!Z_S$)9E+('0(/[_X%M'MH$>,&2PX,Y<"3.R)Y4Q&TI?L7MB#I<%\WQB-?%3,8-DK!,]'< E+F&Y#=)$1:XLT]T@,P-=1Y*>$R%^NBFS9 M/>.J^T)=..XIB MT>;?-,*/'/Q;R+\!4$L! A0#% @ ,#![5HF&QN, ! R0\ !$ M ( ! &AT:6$M,C R,S S,C'-D4$L! A0#% @ ,#![ M5CPZ!@U:V*X!2Q0P $"8 5 M " 8\- !H=&EA+3(P,C,P,S(W7VQA8BYX;6Q02P$"% ,4 " P,'M6 MZ#VJAWH( "79@ %0 @ &'&@ :'1I82TR,#(S,#,R-U]P M&UL4$L! A0#% @ ,#![5BB^.VQZ& *7X !( M ( !-", '1M,C,Q,#4X,V0Q7SAK+FAT;5!+ 0(4 Q0 ( # P>U;F34\\ MU < !(9 6 " =X[ !T;3(S,3 U.#-D,5]E>#DY+3$N 9:'1M4$L%!@ & 8 C $ .9# $! end